Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced the acquisition of a-tune by Transnetyx, a global leader in outsourced genetic services and a TSCP portfolio company. The acquisition allows the further enhancement of services to animal research facility operations, simplifying data management and saving time and money for users. Terms of the transaction were not disclosed.
Transnetyx, founded in 2000, launched the world’s first fully automated genotyping system for detecting transgenic, knockout, knock-in, SNP and CRISPR mutations in animal research models. Since the first test in 2004, Transnetyx has processed more than 30 million samples worldwide in 24 or 72 hours with 99.97 percent accuracy, and introduced a full suite of complementary services, including Genetic Monitoring, Microbiome Analysis, Transnetyx Tissue, and the Colony + AMI software.
“More than ever, accurate and reproducible research, conducted under the highest ethical standards, is key for discovery,” said Andreas Staubi, CEO of a-tune. “Both Transnetyx and a-tune have partnered with researchers across the globe for many years. We now look to bundle our strengths to better serve the research community. I look forward to our collective future and the world of opportunities in front of us.”
With the acquisition of a-tune, Transnetyx further emphasizes its mission to provide every researcher globally with the most efficient path to discovery. By combining Transnetyx services with world-class software offerings from a-tune, the two companies aim to streamline facility operations and ensure compliance across research organizations worldwide.
“The combined offerings of Transnetyx and a-tune provide an unmatched suite of products and services to a critical set of end-users,” said Bob Dunn, Managing Partner at TSCP. “Thompson Street is excited about the opportunities presented by this acquisition, and we look forward to the continued prospects for growth moving forward.”